These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29269686)

  • 1. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
    Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H
    Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
    Elamin KM; Motoyama K; Higashi T; Yamashita Y; Tokuda A; Arima H
    Int J Biol Macromol; 2018 Jul; 113():386-394. PubMed ID: 29486262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilized, ROS-sensitive β-cyclodextrin-grafted hyaluronic supramolecular nanocontainers for CD44-targeted anticancer drug delivery.
    Zhang X; Wang P; Wang X; Xu Y; Cheng T; Zhang C; Ding J; Shi Y; Ma W; Yu CY; Wei H
    Colloids Surf B Biointerfaces; 2024 Oct; 242():114081. PubMed ID: 39003850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.
    Badwaik V; Liu L; Gunasekera D; Kulkarni A; Thompson DH
    Mol Pharm; 2016 Mar; 13(3):1176-84. PubMed ID: 26900622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
    Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
    Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
    Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
    Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl-β-cyclodextrin.
    Onodera R; Motoyama K; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
    Int J Pharm; 2013 Aug; 452(1-2):116-23. PubMed ID: 23684659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camptothecin-Polysaccharide Co-assembly and Its Controlled Release.
    Yang Y; Zhang YM; Li D; Sun HL; Fan HX; Liu Y
    Bioconjug Chem; 2016 Dec; 27(12):2834-2838. PubMed ID: 27998070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of Cyclodextrin-based Cancer Treatment].
    Motoyama K
    Yakugaku Zasshi; 2015; 135(11):1291-8. PubMed ID: 26521878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prototype of albumin nanoparticles fabricated by supramolecular cyclodextrin-adamantane association.
    Lee S; Lee C; Kim B; Thao LQ; Lee ES; Kim JO; Oh KT; Choi HG; Youn YS
    Colloids Surf B Biointerfaces; 2016 Nov; 147():281-290. PubMed ID: 27522557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy.
    Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H
    Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Cyclodextrin-modified hyaluronic acid-based supramolecular self-assemblies for pH- and esterase- dual-responsive drug delivery.
    Bai Y; Liu CP; Chen D; Liu CF; Zhuo LH; Li H; Wang C; Bu HT; Tian W
    Carbohydr Polym; 2020 Oct; 246():116654. PubMed ID: 32747286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy.
    Zhong L; Xu L; Liu Y; Li Q; Zhao D; Li Z; Zhang H; Zhang H; Kan Q; Wang Y; Sun J; He Z
    Acta Pharm Sin B; 2019 Mar; 9(2):397-409. PubMed ID: 30972285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
    Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
    J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
    Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
    J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts.
    Gotoh K; Kariya R; Alam MM; Matsuda K; Hattori S; Maeda Y; Motoyama K; Kojima A; Arima H; Okada S
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):285-9. PubMed ID: 25446086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Targeting and Lipid Rafts Disrupting Hyaluronic Acid-Cyclodextrin-Based Nanoassembled Structure for Cancer Therapy.
    Lee SY; Ko SH; Shim JS; Kim DD; Cho HJ
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36628-36640. PubMed ID: 30298719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.